Modification of primary and recurrent genital herpes in guinea pigs by passive immunization

Journal of General Virology

Volumn 83, Issue 11, 2002, Pages 2797-2801

  Bourne, Nigel ^a   Pyles, Richard B ^a   Bernstein, David I ^a   Stanberry, Lawrence R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; POLYCLONAL ANTISERUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE SEVERITY; DNA DETERMINATION; EXPERIMENTAL INFECTION; GENITAL HERPES; GENITAL SYSTEM; GUINEA PIG; HERPES SIMPLEX VIRUS 2; LATENT VIRUS INFECTION; NONHUMAN; PASSIVE IMMUNIZATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECURRENT INFECTION; SPINAL GANGLION; VIRAL SKIN DISEASE; VIRUS REPLICATION;

ANIMALIA; CAVIA; CAVIA PORCELLUS; DNA VIRUSES; HERPES; HUMAN HERPESVIRUS 2; SUS SCROFA;

EID: 0036842958     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-11-2797     Document Type: Article

References (17)

1. Bernstein, D. I. & Harrison, C. J. (1989). Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections. Antimicrobial Agents and Chemotherapy 33, 1511-1515.
2. Bernstein, D. I., Stanberry, L. R., Harrison, C. J., Kappes, J. & Myers, M. G. (1986). Antibody response, recurrence pattern and subsequent herpes simplex virus type 2 (HSV-2) re-infection following initial HSV-2 infection of guinea pigs: effects of acyclovir. Journal of General Virology 67, 1601-1612.
3. Bourne, N., Stanberry, L. R., Bernstein, D. I. & Lew, D. (1996). DNA immunization against experimental genital herpes simplex virus infection. Journal of Infectious Diseases 173, 800-807.
4. Kavaliotis, J., Loukou, I., Trachana, M., Gombakis, N., Tsargaropoulou-Stigga, H. & Koliouskas, D. (1998). Outbreak of varicella in a pediatric oncology unit. Medical and Pediatric Oncology 31, 166-169.
5. Klein, R. J. (1980). Effect of immune serum on the establishment of herpes simplex virus infection in trigeminal ganglia of hairless mice. Journal of General Virology 49, 401-405.
6. McKendall, R. R., Klassen, T. & Baringer, J. R. (1979). Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infection and Immunity 23, 305-311.
7. Morrison, L. A., Zhu, L. & Thebeau, L. G. (2001). Vaccine-induced serum immunoglobulin contributes to protection from herpes simplex virus type 2 genital infection in the presence of immune T cells. Journal of Virology 75, 1195-1204.
8. Oakes, J. E. & Rosemund-Hornbeak, H. (1978). Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infection and Immunity 21, 489-495.
9. Sawyer, L. A. (2000). Antibodies for the prevention and treatment of viral diseases. Antiviral Research 47, 57-77.
10. Shimeld, C. T., Hill, J., Blyth, W. A. & Easty, D. L. (1990). Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system. Journal of General Virology 71, 681-687.
11. Snydman, D. R. (1990). Cytomegalovirus immunoglobulins in the prevention and treatment of cytomegalovirus disease. Reviews of Infectious Diseases 12 (Suppl. 7), 839-847.
12. Stanberry, L. R., Kern, E. R., Richards, J. T., Abbott, T. M. & Overall, J. C., Jr (1982). Genital herpes in guinea pigs: pathogenesis of the primary infection and description of recurrent disease. Journal of Infectious Diseases 146, 397-401.
13. Stanberry, L. R., Kern, E. R., Richards, J. T. & Overall, J. C., Jr (1985). Recurrent genital herpes simplex virus infection in guinea pigs. Intervirology 24, 226-231.
14. Stanberry, L. R., Bernstein, D. I., Burke, R. L., Pachl, C. & Myers, M. G. (1987). Recombinant herpes simplex virus glycoprotein vaccine protects against initial and recurrent genital herpes. Journal of Infectious Diseases 155, 397-404.
15. Wachsman, M., Kulka, M., Smith, C. C. & Aurelian, L. (2001). A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs. Vaccine 19, 1879-1890.
16. Walz, M.A., Yamamoto, H. & Notkins, A. L. (1976). Immunologic response restricts number of cells in sensory ganglia infected with herpes simplex virus. Nature 264, 554-556.
17. Zaia, J. A., Levin, M. J., Preblud, S. R., Leszczynski, J., Wright, G. G., Ellis, R. J., Curtis, A. C., Valerio, M. A. & LeGore, J. (1983). Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. Journal of Infectious Diseases 147, 737-743.